Study design: This will be a randomized, fully-blind, placebo-controlled trial, with allocation 1:1.
Study population: Children aged 13- 120 months, hospitalized or requiring a visit to the emergency department due to acute gastroenteritis (AGE) lasting at least 24 h, but no longer than 72 h at the